RNAC

Cartesian Therapeutics, Inc.

$7.01-0.08 (-1.13%)
Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

Cartesian Therapeutics, Inc. (RNAC) is a publicly traded company with 3 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 3 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.

Latest Insider Transactions

Showing 10 of 41 transactions (past 365 days)

RNAC
10% Owner
Exercise Conversion
$0
Hoge Elizabeth758,001 shares @ $0.00
Filed 2026-04-06Trade 2026-04-02
RNAC
10% Owner
Exercise Conversion
$0
Kalayoglu Murat758,001 shares @ $0.00
Filed 2026-04-06Trade 2026-04-02
RNAC
Director
Gift
$0
Singer Michael6,555 shares @ $0.00
Filed 2026-03-13Trade 2026-03-13
RNAC
CMO
Sale
-$24.4K
Miljkovic Milos3,573 shares @ $6.82
Filed 2026-01-08Trade 2026-01-06
RNAC
CEO
Sale
-$162.1K
Brunn Carsten23,766 shares @ $6.82
Filed 2026-01-08Trade 2026-01-06
RNAC
CFO
Sale
-$72.2K
Davis Blaine10,591 shares @ $6.82
Filed 2026-01-08Trade 2026-01-06
RNAC
CFO
Award
$0
Davis Blaine37,000 shares @ $0.00
Filed 2026-01-06Trade 2026-01-02
RNAC
Director
Award
$0
Zenner Patrick J7,800 shares @ $0.00
Filed 2026-01-06Trade 2026-01-02
RNAC
Director
Award
$0
Springer Timothy A7,800 shares @ $0.00
Filed 2026-01-06Trade 2026-01-02
RNAC
Director
Award
$0
Desilva Nishan M7,800 shares @ $0.00
Filed 2026-01-06Trade 2026-01-02

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Cluster Buy Signals →All Insider Signals →Top Insider Buying →